Literature DB >> 31704714

NRF2-Independent Regulation of Intestinal Constitutive Androstane Receptor by the Pro-Oxidants Cadmium and Isothiocyanate in hUGT1 Mice.

Miles Paszek1, Robert H Tukey2.   

Abstract

Environmental toxicants such as heavy metals from contaminated water or soil and isothiocyanates (ITC) from dietary sources act as pro-oxidants by directly generating reactive oxygen species (ROS) or through depleting cellular antioxidants such as glutathione. Toxicants can alter drug metabolism, and it was reported that CYP2B10 and UGT1A1 are induced by phenethyl isothiocyanate (PEITC) through the constitutive androstane receptor (CAR). The possibility that nuclear factor erythroid 2-related factor 2 (NRF2), the master regulator of the antioxidant response, could coactivate CAR was investigated in neonatal hUGT1/Nrf2 -/- mice. Neonatal mice were treated with PEITC or cadmium (Cd2+) by oral gavage for 2 days. Both PEITC and Cd2+ induced UGT1A1 RNA and protein in intestinal tissues in both hUGT1/Nrf2 +/- and hUGT1/Nrf2 -/- neonates, indicating NRF2-independent regulation of UGT1A1. Increases in CYP2B10 RNA in intestinal tissues were observed following PEITC or Cd2+ exposure. Activation of intestinal CAR by Cd2+ exposure was directly assessed by nuclear fractionation and Western blot analyses at 0.5, 1, 2, and 4 hours after treatment in hUGT1 neonates and after 48 hours in hUGT1/Nrf2 +/- and hUGT1/Nrf2 -/- neonates. CAR localized to the nucleus independently of NRF2 48 hours after exposure. Substantial CAR localization to the nucleus occurred at the 2- and 4-hour time points, coinciding with a decrease in phosphorylation of cytoplasmic extracellular signal-regulated kinases 1 and 2 and a nuclear increase in P38/p-P38 content. This suggests that a novel oxidative stress-MAPK-CAR axis exists with phenotypic consequences. SIGNIFICANCE STATEMENT: Pro-oxidant toxicants can alter drug metabolism through activation of CAR, independent of the NRF2-KEAP1 signaling pathway. Changes in proteins associated with drug metabolism and linked to increases in intestinal maturation are mediated through an oxidative stress-MAPK-CAR axis.
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31704714      PMCID: PMC6904881          DOI: 10.1124/dmd.119.089508

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  33 in total

1.  The role of chrysin and the ah receptor in induction of the human UGT1A1 gene in vitro and in transgenic UGT1 mice.

Authors:  Jessica A Bonzo; Alain Bélanger; Robert H Tukey
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

2.  Dab2, megalin, cubilin and amnionless receptor complex might mediate intestinal endocytosis in the suckling rat.

Authors:  María D Vázquez-Carretero; Marta Palomo; Pablo García-Miranda; Inmaculada Sánchez-Aguayo; María J Peral; María L Calonge; Anunciación A Ilundain
Journal:  J Cell Biochem       Date:  2014-03       Impact factor: 4.429

3.  Interplay between metabolic identities in the intestinal crypt supports stem cell function.

Authors:  Maria J Rodríguez-Colman; Matthias Schewe; Maaike Meerlo; Edwin Stigter; Johan Gerrits; Mia Pras-Raves; Andrea Sacchetti; Marten Hornsveld; Koen C Oost; Hugo J Snippert; Nanda Verhoeven-Duif; Riccardo Fodde; Boudewijn M T Burgering
Journal:  Nature       Date:  2017-03-08       Impact factor: 49.962

4.  Active ERK1/2 protein interacts with the phosphorylated nuclear constitutive active/androstane receptor (CAR; NR1I3), repressing dephosphorylation and sequestering CAR in the cytoplasm.

Authors:  Makoto Osabe; Masahiko Negishi
Journal:  J Biol Chem       Date:  2011-08-26       Impact factor: 5.157

5.  Intestinal NCoR1, a regulator of epithelial cell maturation, controls neonatal hyperbilirubinemia.

Authors:  Shujuan Chen; Wenqi Lu; Mei-Fei Yueh; Eva Rettenmeier; Miao Liu; Miles Paszek; Johan Auwerx; Ruth T Yu; Ronald M Evans; Kepeng Wang; Michael Karin; Robert H Tukey
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-06       Impact factor: 11.205

6.  Intestinal epithelial cell differentiation involves activation of p38 mitogen-activated protein kinase that regulates the homeobox transcription factor CDX2.

Authors:  M Houde; P Laprise; D Jean; M Blais; C Asselin; N Rivard
Journal:  J Biol Chem       Date:  2001-03-30       Impact factor: 5.157

7.  Development of human liver UDP-glucuronosyltransferases.

Authors:  B Burchell; M Coughtrie; M Jackson; D Harding; S Fournel-Gigleux; J Leakey; R Hume
Journal:  Dev Pharmacol Ther       Date:  1989

8.  Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes.

Authors:  Qinghang Liu; Polly A Hofmann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-02-12       Impact factor: 4.733

Review 9.  How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.

Authors:  Dariusz Ratman; Wim Vanden Berghe; Lien Dejager; Claude Libert; Jan Tavernier; Ilse M Beck; Karolien De Bosscher
Journal:  Mol Cell Endocrinol       Date:  2012-12-23       Impact factor: 4.102

10.  Coordinated regulation of nuclear receptor CAR by CCRP/DNAJC7, HSP70 and the ubiquitin-proteasome system.

Authors:  Yoav E Timsit; Masahiko Negishi
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

View more
  2 in total

1.  Cadmium exposure modulates the gut-liver axis in an Alzheimer's disease mouse model.

Authors:  Angela Zhang; Megumi Matsushita; Liang Zhang; Hao Wang; Xiaojian Shi; Haiwei Gu; Zhengui Xia; Julia Yue Cui
Journal:  Commun Biol       Date:  2021-12-15

2.  Regulation of Intestinal UDP-Glucuronosyltransferase 1A1 by the Farnesoid X Receptor Agonist Obeticholic Acid Is Controlled by Constitutive Androstane Receptor through Intestinal Maturation.

Authors:  André A Weber; Elvira Mennillo; Xiaojing Yang; Lori W E van der Schoor; Johan W Jonker; Shujuan Chen; Robert H Tukey
Journal:  Drug Metab Dispos       Date:  2020-11-05       Impact factor: 3.922

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.